Reactor production of Thorium-229
Journal Article
·
· Applied Radiation and Isotopes
- Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States)
Limited availability of 229Th for clinical applications of 213Bi necessitates investigation of alternative production routes. In reactor production, 229Th is produced from neutron transmutation of 226Ra, 228Ra, 227Ac and 228Th. Here, we evaluate irradiations of 226Ra, 228Ra, and 227Ac targets at the ORNL High Flux Isotope Reactor.
- Research Organization:
- Oak Ridge National Laboratory (ORNL), Oak Ridge, TN (United States)
- Sponsoring Organization:
- USDOE Office of Nuclear Energy (NE)
- Grant/Contract Number:
- AC05-00OR22725
- OSTI ID:
- 1253240
- Alternate ID(s):
- OSTI ID: 1358796
- Journal Information:
- Applied Radiation and Isotopes, Vol. 114, Issue C; ISSN 0969-8043
- Publisher:
- ElsevierCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Cited by: 20 works
Citation information provided by
Web of Science
Web of Science
Development of 225 Ac Radiopharmaceuticals: TRIUMF Perspectives and Experiences
|
journal | October 2018 |
Similar Records
ORNL production of the experimental alpha emitters bismuth-213 and actinium-225 for medical applications
Production of Thorium-229 at the ORNL High Flux Isotope Reactor
Final Technical Report - A Novel Radium-Selective Separation Technique to Improve the Production of 225Ac for Cancer Immunotherapy
Journal Article
·
Tue Sep 01 00:00:00 EDT 1998
· Transactions of the American Nuclear Society
·
OSTI ID:1253240
Production of Thorium-229 at the ORNL High Flux Isotope Reactor
Conference
·
Tue Jan 01 00:00:00 EST 2008
·
OSTI ID:1253240
Final Technical Report - A Novel Radium-Selective Separation Technique to Improve the Production of 225Ac for Cancer Immunotherapy
Technical Report
·
Thu May 11 00:00:00 EDT 2023
·
OSTI ID:1253240